Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus

Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy

(2015) Chung-Ze Wu et al.   CLINICAL BIOCHEMISTRY

Soluble Urokinase Receptor and Chronic Kidney Disease

(2015) Salim S. Hayek et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor–Mediated Podocyte β3-integrin Activation

(2015) Oliver Staeck et al.   TRANSPLANTATION

A New Paradigm to Understand and Treat Diabetic Neuropathy

(2014) A. Hidmark et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

(2014) S. Theilade et al.   JOURNAL OF INTERNAL MEDICINE

Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease

(2014) T.-H. Yoo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease

(2014) Takehiko Wada et al.   KIDNEY INTERNATIONAL

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis

(2014) Björn Meijers et al.   KIDNEY INTERNATIONAL

BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats

(2014) Laura A. Maile et al.   Journal of Diabetes Research

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status

(2013) A. Heraclides et al.   DIABETOLOGIA

suPAR: The Molecular Crystal Ball

(2013) Maria Thunø et al.   DISEASE MARKERS

Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria)

(2013) E. Imai et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

(2011) D. B. Sacks et al.   DIABETES CARE

The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men

(2011) S. B. Haugaard et al.   DIABETIC MEDICINE

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

(2011) Changli Wei et al.   NATURE MEDICINE

The estimation of average hazard ratios by weighted Cox regression

(2009) Michael Schemper et al.   STATISTICS IN MEDICINE